is phentermine a glp-1 receptor agonist What You Need to Know About Semaglutide and New global study ranks most

Mol Metab 2021;51:101237.ArticlePubMedPMC 10

A recent analysis of FDA adverse event reporting system (FAERS) data from 2004 to 2020 revealed a notable association between GLP-1 RAs and malignant pancreatic neoplasms (proportional reporting ratio [PRR], 9.86) [52]

Retatrutide targets GLP-1, GIP, and glucagon receptors

These may include: Feeling sick (nausea) Tummy pain Diarrhoea or constipation Headache Rare but serious side effects: Inflammation of the pancreas (very bad tummy pain, which travels to your back) Gallbladder problems Allergic reactions Always tell your doctor if you feel unwell while taking these medicines

Safety, Side Effects, and Personalized Monitoring As with any medication, semaglutide may have side effects, including gastrointestinal symptoms such as nausea or diarrhea, especially at the start of treatment

Covers weight loss efficacy, cardiovascular data, liver fat reduction, and regulatory status